Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive dyskinesia.

K E Clyne, R Juhl

    American Journal of Hospital Pharmacy
    |May 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Tardive dyskinesia (TD), a neurological disorder causing involuntary movements, can result from antipsychotic drug use. Treatment options exist but often involve small patient studies, requiring careful consideration of drug effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Case report: oxaprozin and fatal toxic epidermal necrolysis.

    The Journal of burn care & rehabilitation·1998
    Same author

    Pharmacy-based skin-testing program in a community hospital.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996
    Same author

    Responding to a physician's request to mislabel a patient's prescription.

    American journal of hospital pharmacy·1991
    Same author

    Antibiotic sensitivity and the prescribing information sheet: assisting the prescribing physician.

    American journal of infection control·1990
    Same author

    Maintaining patient confidentiality in a case of potential substance abuse.

    American journal of hospital pharmacy·1989
    Same author

    A microcomputer generated individualized pediatric emergency drug list.

    The Nebraska medical journal·1985

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary movements of the lips, jaws, and tongue.
    • It is typically associated with short-term or long-term antipsychotic drug therapy.
    • Several classes of antipsychotic drugs, including phenothiazines and butyrophenones, have the potential to induce TD.

    Purpose of the Study:

    • To discuss the etiology, pharmacology, treatment, and potential prevention of tardive dyskinesia (TD).

    Main Methods:

    • Review of existing literature on the causes and mechanisms of TD.
    • Discussion of various pharmacological approaches for TD treatment.
    • Analysis of drug effectiveness based on available studies.

    Main Results:

    Related Experiment Videos

    • Antipsychotic medications are a primary cause of TD.
    • Various drug classes can induce this condition.
    • Treatment strategies involve dopamine-depleting agents, dopamine-blocking agents, and cholinomimetics.

    Conclusions:

    • While treatments for TD exist, their effectiveness is often based on studies with small patient numbers.
    • Further research with larger cohorts is needed to confirm treatment efficacy.
    • Understanding the etiology and pharmacology is crucial for prevention and management strategies.